Work

397 Preoperative trastuzumab and vinorelbine (HN) is a well-tolerated, active regimen for Her2 3+/FISH+stage II/III breast cancer

Year: 2003

Type: conference-abstract

Source: European Journal of Cancer Supplements

DOI: 10.1016/s1359-6349(03)90429-0

Authors: L.N. Harris, H. Burstein, R. Gelman, P. Freidman, I. Kuter, V. Borges, C. Kaelin, J. Bellon, D. Smith, E. Winer

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2013882331

Cites:

Cited by: 26

Related to: 10